Showing posts with label Pertuzumab. Show all posts
Showing posts with label Pertuzumab. Show all posts
Saturday, May 21, 2011
Tuesday, February 02, 2010
Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Note: The response rates in this study either alone or in combination were low. The side effects appear to be understated (abstract).
add your opinions
Gemcitabine
,
lancet oncology ovarian cancer detection study
,
Pertuzumab
Subscribe to:
Posts
(
Atom
)